Read the latest positive news, breakthroughs, and inspiring stories about johns hopkins, curated daily by BrightWire.
Scientists at Johns Hopkins discovered pulse oximeters suddenly switched from overestimating to underestimating blood oxygen levels, offering fresh hope for fixing medical devices that have long failed patients of color. The unexpected finding could lead to more accurate diagnosis tools for everyone.
Johns Hopkins researchers have captured the first detailed views of how human cells repair the most dangerous type of genetic damage. The breakthrough could lead to better cancer treatments and safer gene editing.
After years of debilitating headaches and brain fog, Elizabeth Richwine found relief through a clinical trial using psilocybin therapy in Baltimore. Her story reflects growing medical research showing psychedelics may help treat chronic conditions when traditional medicine falls short.
Scientists at Johns Hopkins have developed a therapy that could reverse Type 1 diabetes shortly after diagnosis by correcting the immune system itself, not just managing blood sugar. The breakthrough, seven years in the making, targets the root cause of the disease that affects 2.1 million Americans.
Scientists discovered a simple chemical swap that helps cells build proteins from mRNA faster and with fewer errors, potentially leading to more effective vaccines using smaller doses. The breakthrough could ease supply shortages during health emergencies.
Johns Hopkins researchers found a chemical tweak that makes mRNA medicines produce proteins nearly twice as fast as current COVID vaccine technology. The discovery could lead to more powerful treatments using smaller doses.
An experimental drug safely activated immune responses against pancreatic cancer in 90% of high-risk patients, offering hope for preventing one of the deadliest cancers. After two years, none of the participants developed cancer.
A new vaccine prevented pancreatic cancer from developing in 20 high-risk patients, with 90% showing lasting immune responses. For the first time, researchers have found a way to intercept one of the deadliest cancers before it starts.
Johns Hopkins University's athletic department just shattered its fundraising record, pulling in nearly $9 million to support student athletes. The money will help hundreds of competitors access better coaching, mental health resources, and cutting-edge sports science.
New artificial intelligence tools can detect pancreatic cancer more than a year before human doctors spot it on scans, giving patients precious time for treatment. Johns Hopkins researchers say this breakthrough could transform outcomes for one of the deadliest cancers.
Scientists at Johns Hopkins developed a vaccine that may prevent pancreatic cancer before it starts, triggering lasting immune responses in 90% of high-risk patients. None of the 20 participants developed cancer during the study, and some saw their precancerous cysts shrink or disappear.
Johns Hopkins researchers discovered how vitamin A and thyroid hormones help babies develop sharp central vision before birth, overturning a 30-year-old theory. The breakthrough could lead to new treatments for macular degeneration and other blinding diseases.